OOIR: Observatory of International Research

Papers

(The H4-Index of JACC: Cardiooncology is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Addressing the Overlooked	99
Driven by Impact, Not Impact Factor	97
The Pursuit of “Best” Anticoagulant for Cancer-Associated Thrombosis	97
Atrial Fibrillation in Patients With Cancer	86
Full Issue PDF	86
LAAO in Cardio-Oncology	83
Full Issue PDF	77
Editorial Board	69
Determining Cause-Specific Mortality in Cancer Survivors	68
Editorial Board	67
JACC: CardioOncology	59
Editorial Board	58
Acute Myocardial Infarction and Chronic Myeloproliferative Neoplasms	54
Clinical Practice Guidelines in Cardio-Oncology	51
Reply	44
Takotsubo Cardiomyopathy Associated With Checkpoint Inhibitor Therapy	44
Performance Status and Long-Term Outcomes in Cancer-Associated Pulmonary Embolism	39
Understanding and Reducing the Social and Environmental Determinants of Health Disparities in Cardio-Oncology	38
Adding a Rock to a Hard Place	37
PULMONARY VASCULAR TOXICITY WITH TYROSINE KINASE INHIBITOR THERAPY: A RARE CASE IN A CHRONIC MYELOID LEUKEMIA PATIENT	36
PALLIATIVE RESECTION OF A CARDIAC SARCOMA	34
PREVALENCE OF IMPAIRED CARDIORESPIRATORY FITNESS & ITS CONTRIBUTORS IN LUNG CANCER PATIENTS PRIOR TO RADIOTHERAPY	34
Delayed Diagnosis and Recovery of Fulminant Immune Checkpoint Inhibitor-Associated Myocarditis on VA-ECMO Support	33
Reversible Myocardial Edema Secondary to Tagraxofusp-Induced Capillary Leak Syndrome	33
Cardiac Surveillance in Immune Checkpoint Inhibitor Therapy	33

Immune Checkpoint Inhibitor Myocarditis Treatment Strategies and Future Directions	32
Outcomes of Surgery in Cardiac Angiosarcoma	31
Reply	31
ER-Specific Autophagy or ER-Phagy in Cardiac Myocytes Protects the Heart Against Doxorubicin-Induced Cardiotoxicity	30
Editorial Board/Officers Page	30